Company: NCEL
Filing Date: 2025-09-25
Form Type: F-1
Source: 0001213900-25-091697
Chunk: 123

Company: NewcelX Ltd.
Filing Date: 2025-09-25
Form: F-1
Chunk 123
---
reements”) and together with the Short Term Loan
Agreement, the Bridge Loan Agreements, with certain existing shareholders of the Company, including Ronald Hafner, the Company’s
Chairman of the Board of Directors, Felix Grisard, Jürgen Bauer, and Maria Nayvalt (together, the “Bridge Lenders”) and
the Short Term Lender, providing for an unsecured loan to the Company in the aggregate amount of CHF 875,000.00 (approximately $1,000,000.00)
(the “Bridge Loan”). Pursuant to the Bridge Loan Agreements, the Bridge Loans bear interest at a rate of 10% per annum and
mature on the earlier of June 30, 2024 or a liquidity event with a strategic partner.

<div align='center'>II-1</div>

On March 18, 2024, we
entered into an addendum to the Short Term Loan Agreement with the Short Term Lender, and a series of addendums to the Bridge Loan Agreements
with the Bridge Lenders, each providing for an extension of the maturity date to December 31, 2024.

On May 13, 2024, we entered
into the second addendum to the Short Term Loan Agreement, and a short term addendum to the Bridge Loan Agreements, with the Short Term
Lender each providing for an extension of the maturity date to June 30, 2025. On October 10, 2024, the Company successfully
implemented a restructuring measure by converting the claims of debt holders.

On March 20, 2024, we
entered into a securities purchase agreement, providing for the issuance in a registered direct offering of 7,000,000 Common Shares, at
a purchase price of $0.25 per share (the “March Purchase Agreement”). The offering closed on March 22, 2024. In addition,
pursuant to the March Purchase Agreement, the investors received unregistered warrants to purchase up to an aggregate of 3,500,000 Common
Shares at an exercise of $0.25 per share in a concurrent private placement (the “Common Warrants”). The Common Warrants were
immediately exercisable upon issuance and will expire five years following the date of issuance. The March Purchase Agreement contains
customary representations and warranties and agreements of the Company and the investors and customary indemnification rights and obligations
of the parties. Pursuant to the March